Unlocking ATP13A2/PARK9 activity.
作者信息
Martin Shaun, Holemans Tine, Vangheluwe Peter
机构信息
a Laboratory of Cellular Transport Systems ; Department of Cellular and Molecular Medicine; ON1 Campus Gasthuisberg ; KU Leuven ; Leuven , Belgium.
出版信息
Cell Cycle. 2015;14(21):3341-2. doi: 10.1080/15384101.2015.1093420.
Abstract
摘要
相似文献
1
Unlocking ATP13A2/PARK9 activity.
Cell Cycle. 2015;14(21):3341-2. doi: 10.1080/15384101.2015.1093420.
2
A lipid switch unlocks Parkinson's disease-associated ATP13A2.
Proc Natl Acad Sci U S A. 2015 Jul 21;112(29):9040-5. doi: 10.1073/pnas.1508220112. Epub 2015 Jul 1.
3
Parkinson's disease-linked human PARK9/ATP13A2 maintains zinc homeostasis and promotes α-Synuclein externalization via exosomes.
Hum Mol Genet. 2014 Jun 1;23(11):2816-33. doi: 10.1093/hmg/ddu099. Epub 2014 Mar 6.
4
The Parkinson-associated human P5B-ATPase ATP13A2 modifies lipid homeostasis.
Biochim Biophys Acta Biomembr. 2019 Oct 1;1861(10):182993. doi: 10.1016/j.bbamem.2019.05.015. Epub 2019 May 24.
5
Structural basis of polyamine transport by human ATP13A2 (PARK9).
Mol Cell. 2021 Nov 18;81(22):4635-4649.e8. doi: 10.1016/j.molcel.2021.08.017. Epub 2021 Oct 28.
6
Parkinson disease related ATP13A2 evolved early in animal evolution.
PLoS One. 2018 Mar 5;13(3):e0193228. doi: 10.1371/journal.pone.0193228. eCollection 2018.
7
Hypoxia regulation of ATP13A2 (PARK9) gene transcription.
J Neurochem. 2012 Jul;122(2):251-9. doi: 10.1111/j.1471-4159.2012.07676.x. Epub 2012 Feb 17.
8
Parkinson's disease-associated human P5B-ATPase ATP13A2 increases spermidine uptake.
Biochem J. 2013 Feb 15;450(1):47-53. doi: 10.1042/BJ20120739.
9
The role of ATP13A2 in Parkinson's disease: Clinical phenotypes and molecular mechanisms.
Mov Disord. 2015 May;30(6):770-9. doi: 10.1002/mds.26243. Epub 2015 Apr 21.
10
α-Synuclein-induced dopaminergic neurodegeneration in a rat model of Parkinson's disease occurs independent of ATP13A2 (PARK9).
Neurobiol Dis. 2015 Jan;73:229-43. doi: 10.1016/j.nbd.2014.10.007. Epub 2014 Oct 18.
引用本文的文献
1
Case Report: Novel pathogenic variants associated with early-onset parkinsonism and a mini-review.
Front Genet. 2025 Jul 29;16:1588812. doi: 10.3389/fgene.2025.1588812. eCollection 2025.
2
Genetic Evidence for Endolysosomal Dysfunction in Parkinson's Disease: A Critical Overview.
Int J Mol Sci. 2023 Mar 28;24(7):6338. doi: 10.3390/ijms24076338.
3
ATP13A2 protects dopaminergic neurons in Parkinson's disease: from biology to pathology.
J Biomed Res. 2022 Mar 28;36(2):98-108. doi: 10.7555/JBR.36.20220001.
4
Cryo-EM structures and transport mechanism of human P5B type ATPase ATP13A2.
Cell Discov. 2021 Nov 2;7(1):106. doi: 10.1038/s41421-021-00334-6.
5
ATP13A2 deficiency disrupts lysosomal polyamine export.
Nature. 2020 Feb;578(7795):419-424. doi: 10.1038/s41586-020-1968-7. Epub 2020 Jan 29.
6
Mutations in ATP13A2 (PARK9) are associated with an amyotrophic lateral sclerosis-like phenotype, implicating this locus in further phenotypic expansion.
Hum Genomics. 2019 Apr 16;13(1):19. doi: 10.1186/s40246-019-0203-9.
7
Exacerbation of sensorimotor dysfunction in mice deficient in Atp13a2 and overexpressing human wildtype alpha-synuclein.
Behav Brain Res. 2018 May 2;343:41-49. doi: 10.1016/j.bbr.2018.01.029. Epub 2018 Feb 3.
8
Loss-of-function mutations in the ATP13A2/PARK9 gene cause complicated hereditary spastic paraplegia (SPG78).
Brain. 2017 Feb;140(2):287-305. doi: 10.1093/brain/aww307.
9
Protection against Mitochondrial and Metal Toxicity Depends on Functional Lipid Binding Sites in ATP13A2.
Parkinsons Dis. 2016;2016:9531917. doi: 10.1155/2016/9531917. Epub 2016 Mar 17.
本文引用的文献
1
A lipid switch unlocks Parkinson's disease-associated ATP13A2.
Proc Natl Acad Sci U S A. 2015 Jul 21;112(29):9040-5. doi: 10.1073/pnas.1508220112. Epub 2015 Jul 1.
2
The Parkinson-associated human P5B-ATPase ATP13A2 protects against the iron-induced cytotoxicity.
Biochim Biophys Acta. 2015 Aug;1848(8):1646-55. doi: 10.1016/j.bbamem.2015.04.008. Epub 2015 Apr 23.
3
Cellular function and pathological role of ATP13A2 and related P-type transport ATPases in Parkinson's disease and other neurological disorders.
Front Mol Neurosci. 2014 May 27;7:48. doi: 10.3389/fnmol.2014.00048. eCollection 2014.
4
Phosphatidic acid (PA)-preferring phospholipase A1 regulates mitochondrial dynamics.
J Biol Chem. 2014 Apr 18;289(16):11497-11511. doi: 10.1074/jbc.M113.531921. Epub 2014 Mar 5.
5
Identification of novel ATP13A2 interactors and their role in α-synuclein misfolding and toxicity.
Hum Mol Genet. 2012 Sep 1;21(17):3785-94. doi: 10.1093/hmg/dds206. Epub 2012 May 29.
6
A critical role of mitochondrial phosphatase Ptpmt1 in embryogenesis reveals a mitochondrial metabolic stress-induced differentiation checkpoint in embryonic stem cells.
Mol Cell Biol. 2011 Dec;31(24):4902-16. doi: 10.1128/MCB.05629-11. Epub 2011 Oct 10.
Zotero 插件